Nascent Biotech, Inc. (NBIO)
OTCMKTS: NBIO · Delayed Price · USD
0.00 (0.00%)
Jun 17, 2024, 2:30 PM EDT - Market closed

Nascent Biotech Statistics

Total Valuation

NBIO has a market cap or net worth of $15.26 million. The enterprise value is $14.76 million.

Market Cap 15.26M
Enterprise Value 14.76M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

NBIO has 169.73 million shares outstanding. The number of shares has increased by 39.95% in one year.

Shares Outstanding 169.73M
Shares Change (YoY) +39.95%
Shares Change (QoQ) +12.64%
Owned by Insiders (%) 40.00%
Owned by Institutions (%) 0.63%
Float 93.95M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 502.48
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.05, with a Debt / Equity ratio of 4.12.

Current Ratio 1.05
Quick Ratio n/a
Debt / Equity 4.12
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -3.66

Financial Efficiency

Return on equity (ROE) is -6,892.89% and return on invested capital (ROIC) is -1,450.55%.

Return on Equity (ROE) -6,892.89%
Return on Assets (ROA) -326.40%
Return on Capital (ROIC) -1,450.55%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a


Income Tax -152,271
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +47.38% in the last 52 weeks. The beta is -3.14, so NBIO's price volatility has been lower than the market average.

Beta (1Y) -3.14
52-Week Price Change +47.38%
50-Day Moving Average 0.10
200-Day Moving Average 0.13
Relative Strength Index (RSI) 43.20
Average Volume (30 Days) 58,324

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit -2
Operating Income -2.25M
Pretax Income -2.09M
Net Income -2.09M
EBIT -2.87M
Earnings Per Share (EPS) -$0.01
Full Income Statement

Balance Sheet

The company has $623,854 in cash and $125,000 in debt, giving a net cash position of $498,854 or $0.00 per share.

Cash & Cash Equivalents 623,854
Total Debt 125,000
Net Cash 498,854
Net Cash Per Share $0.00
Equity / Book Value 30,367
Book Value Per Share 0.00
Working Capital 30,366
Full Balance Sheet

Cash Flow

Operating Cash Flow -1.22M
Capital Expenditures n/a
Free Cash Flow -1.22M
FCF Per Share -$0.01
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NBIO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -39.95%
Shareholder Yield -39.95%
Earnings Yield -13.72%
FCF Yield -8.00%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


Altman Z-Score n/a
Piotroski F-Score 2